重组抗荧光素单抗(4-4-20 (enhanced)),人Fab fragment Kappa(His-tag) | Syd Labs PA007702.hfhis

重组抗荧光素单抗(4-4-20 (enhanced)),人Fab fragment Kappa(His-tag) Syd Labs PA007702.hfhis

重组抗荧光素单抗(4-4-20 (enhanced)),人Fab fragment Kappa(His-tag) | Syd Labs PA007702.hfhis

In stock

一键复制

Syd Labs体内实验级重组抗荧光素(Anti-Fluorescein / Anti-FITC)单克隆抗体的‌人源Fab片段(Human Fab fragment Kappa),C端融合6×His标签‌,克隆号 4-4-20(enhanced,亲和力增强版),由哺乳动物细胞重组表达(重链Fd段VH-CH1 + 完整人Kappa轻链,Fd段或轻链C端融合六聚组氨酸标签6×His,His-tag序列HHHHHH,无铰链区、CH2、CH3结构域),序列明确、无酶切异质性、标签位置确定,特异性识别荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及FITC-蛋白/核酸/葡聚糖偶联物具有亚纳摩尔级高亲和力(K_d ~ 10⁻¹⁰ M)。Fab-His片段在无Fc段Fab的基础上融合6×His标签,兼具以下核心特性:①‌完全无Fc效应‌——不结合FcγR/C1q/FcRn,无ADCC/CDC,流式/IHC背景极低;②‌分子量小(约51 kDa)‌——50 kDa Fab + ~0.8 kDa His-tag,组织穿透性好,体内成像快速清除;③‌单价结合‌——仅一个抗原结合位点,不交联抗原;④‌6×His标签通用亲和纯化与检测‌——可通过Ni-NTA(镍柱)或Co²⁺-NTA(钴柱)固定化金属亲和层析(IMAC)一步纯化,无需Protein A/G或抗原亲和柱;可直接用抗His标签抗体(Anti-His-tag mAb,如克隆HIS.H8/27E8/6G2A9)做Western Blot/ELISA/流式检测,无需针对人Kappa或Fab的特异性二抗;⑤‌定向固定化‌——His标签可与Ni-NTA芯片/磁珠/板/树脂高亲和定向结合(K_d ~ 10⁻¹³ M在Ni²⁺柱上),实现抗体Fab段抗原结合位点朝外的定向固定,避免随机偶联导致活性损失,特别适合SPR/BLI(Biacore/Octet)亲和力测定、蛋白芯片、Pull-down实验;⑥‌Pull-down与IP友好‌——Ni-NTA磁珠可直接捕获Fab-His-抗原复合物,无需Protein A/G磁珠,无内源IgG重/轻链污染。荧光素(Fluorescein)又称 ‌FITC(异硫氰酸荧光素)、FAM(6-羧基荧光素)、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350‌,是呫吨类绿色荧光染料(Ex≈494 nm/Em≈521 nm)。人Fab-His版本特别适用于:①SPR/BLI生物分子相互作用分析——Ni-NTA芯片定向固定化抗FITC Fab-His捕获FITC标记分子,或作为FITC-抗原结合实验的对照;②Ni-NTA磁珠Pull-down/免疫沉淀(IP)小蛋白复合物——小分子量Fab穿透好、无IgG重轻链污染;③蛋白芯片/微孔板定向包被——His标签介导定向固定,提高抗原结合活性;④Western Blot/ELISA检测FITC标记蛋白——抗His-HRP直接检测,节省种属特异二抗;⑤流式低背景检测+抗His二级检测;⑥侧向流试纸条His-tag介导固定化;⑦双特异性抗体/多价构建的Fab模块(His-tag便于纯化与检测)。本品经Ni-NTA IMAC亲和纯化,还原性SDS-PAGE及HPLC检测纯度>95%,0.2 μM过滤于1×PBS溶液(不含EDTA/DTT,防止His-tag金属螯合解离),适用于SPR/BLI、Pull-down/IP、WB、ELISA、流式、IHC/IF及蛋白芯片。

SKU: PA007702.hfhis 分类: ,

产品参数

货号 PA007702.hfhis
产品名称重组抗荧光素单抗(4-4-20 (enhanced)),人Fab fragment Kappa(His-tag) | Syd Labs PA007702.hfhis
英文名 Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Human Fab fragment Kappa (His-tag)
供货商名称 Syd Labs, Inc.
品牌名 Syd Labs
别称 Fluorescein、FITC(Fluorescein isothiocyanate / 异硫氰酸荧光素 / 荧光素异硫氰酸酯)、FAM(6-Carboxyfluorescein / 6-羧基荧光素)、Fluorescein isomer I、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350、D&C Yellow No.7
克隆号 4-4-20 (enhanced)
同种型 Human Fab fragment Kappa (His-tag)
特异性 特异性结合荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及 FITC-蛋白/抗体/葡聚糖/核酸偶联物均有高亲和力
抗体形式 0.2 μM 过滤的 1× PBS 溶液(不含EDTA/DTT/还原剂,不含咪唑)
纯度 还原性条件下 SDS-PAGE 及 HPLC 检测>95%;还原性电泳可见~26 kDa(Fd-His)与~25 kDa(Kappa轻链)两条带;His-tag暴露完整性经抗His-HRP WB验证
运输 采用冰袋运输;收到后请立即按下方推荐温度保存
稳定性与存储 使用手动除霜冰箱,避免反复冻融;自收货之日起12个月,按供货状态于−20 ℃至−70 ℃保存;自收货之日起1个月,按供货状态于2 ℃至8 ℃保存;避免添加EDTA/DTT/β-巯基乙醇等金属螯合剂或还原剂(会导致His-tag与Ni²⁺解离);如需使用还原/变性条件,建议洗脱后再处理
产品咨询 Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。
关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理)
应用详情 Western Blot(可用抗His-HRP直接检测,无需二抗)、ELISA(His-tag板定向包被或抗His检测)、Flow Cytometry(FcγR高表达细胞低背景检测);可用于 SPR/BLI生物分子互作分析(Ni-NTA芯片定向固定化)、Pull-down/Co-IP(Ni-NTA磁珠)、IHC/IF免疫组化/免疫荧光(深层组织穿透、抗His荧光二抗检测)、侧向流免疫层析(His-tag定向固定化)、蛋白芯片/微孔板定向包被、双特异性抗体构建Fab模块、FITC-抗原-抗体复合物捕获

文献

PA007702.hfhis: Syd Labs 重组抗荧光素单克隆抗体(克隆号4-4-20 (enhanced)) ,人Fab fragment Kappa(His-tag)(Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Human Fab fragment Kappa (His-tag))

重组抗荧光素单抗(4-4-20 (enhanced))背景知识:

我们的重组抗荧光素抗体(克隆号 4-4-20 增强型)为序列明确、哺乳动物细胞表达的抗 FITC 单克隆抗体,可特异性识别结合在蛋白、多肽、核酸或固相基质上的荧光素母核结构。该重组抗荧光素半抗原抗体稳定性高、性能可靠,是识别荧光素标记靶标、在各类常规体外免疫检测中放大信号的关键二步检测试剂,可彻底规避杂交瘤细胞株遗传漂移带来的风险。

相较于传统生物素 – 链霉亲和素体系,荧光素 / 抗荧光素检测体系具备突出优势:生物素广泛存在于多种哺乳动物组织及细胞裂解液中,因此基于生物素的检测往往背景偏高、易出现假阳性;而生物样本中天然不含荧光素,使用这款重组抗 FITC 单克隆抗体能够完全消除内源背景干扰。因此,该抗荧光素半抗原抗体非常适合用于复杂样本的体外诊断、ELISA 以及高通量筛选平台,可获得低背景、高准确度的实验数据。

我们可针对 4-4-20 增强型骨架提供全套抗体定制改造与规模化生产服务,面向诊断试剂盒研发企业及科研实验室。可提供的定制类型包括:
亚型转换与 Fc 改造:多种重链 / 轻链亚型以及改造型 Fc 变体(如效应沉默 LALAPG 突变体);
亲和标签:可重组添加 Avi 标签、His 标签或 DYKDDDDK(FLAG)标签,适配特定实验取向;
标记偶联:生物素化版本,也可直接偶联多种荧光基团、染料以及酶(辣根过氧化物酶 HRP、碱性磷酸酶 AP)。

重组抗荧光素单抗(4-4-20 (enhanced))部分参考文献:

1. CRISPR/Cas12a and fork-shaped probe enhance LAMP-LFT integration for equipment-free detection of Listeria monocytogenes.
Safenkova IV, et al.
Food Res Int. 2026 Apr;230:118592. PMID: 41794473 DOI: 10.1016/j.foodres.2026.118592
“An isothermal amplification assay integrated with lateral flow test (LFT) was developed for equipment-free detection of Listeria monocytogenes. In both LAMP-LFT and LAMP-CRISPR/Cas12a-LFT formats, fluorescein- and biotin-labeled amplicons were detected using a common conjugate of gold nanoparticles and anti-fluorescein (anti-FAM) antibodies, with a cleaved fork-shaped multi-fluorescein probe enabling visual readout on strips coated with anti-FAM capture antibody. The optimized assay achieved a single-cell detection limit (0.2 cells/reaction in buffer, 1 cell/reaction in spiked milk) within 80 min.”

2.A Versatile Cytochemical Labeling Technique as a Forensic Decision-Support Tool for In Situ Detection of Cell-Derived Markers in Invisible Biological Traces.
Bastat M, et al.
Anal Chem. 2025 Oct;97(41):22497–22507. PMID: 41057037 DOI: 10.1021/acs.analchem.5c02284
“A dual chromogenic and fluorescent in situ cytochemistry tool was developed to highlight invisible touch-DNA traces (e.g., fingermark corneocytes) on crime-scene surfaces. Chromogenic labeling of mannose residues and keratin 10 allowed visualization of as few as 100 shed cells, while a combination of FITC-conjugated primary probes and an HRP-conjugated anti-FITC antibody enabled simultaneous chromogenic and fluorescent detection across light and opaque substrates (ceramic, metal), supporting on-field sampling decisions prior to DNA extraction.”

3.Development of Reverse Transcriptase Recombinase Polymerase Amplification Combined with Lateral Flow Dipstick for Rapid Detection of Tilapia Lake Virus (TiLV): Pilot Study.
Srivorakul S, et al.
Vet Sci. 2025 Sep;12(9):845. PMID: 41012770 DOI: 10.3390/vetsci12090845
“A reverse-transcriptase recombinase polymerase amplification assay combined with a lateral flow dipstick (RT-RPA-LFD) was developed for point-of-care detection of Tilapia Lake Virus. The dipstick was prepared with immobilized anti-FITC and anti-biotin capture antibodies compatible with TiLV-specific primers tagged with FITC and biotin. Reverse transcription and RPA amplification were completed at 39 °C within 20 min, and products were visualized as a positive band on the LFD, achieving a 3.19 copies/µL limit of detection—a 100-fold improvement over RT-PCR-LFD.”

4.Identification, sorting and profiling of functional killer cells via the capture of fluorescent target-cell lysate.
Luah YH, et al.
Nat Biomed Eng. 2024 Mar;8(3):248–262. PMID: 37652987 DOI: 10.1038/s41551-023-01089-z
“PAINTKiller, a flow-cytometry-compatible assay for identifying and sorting functional cytotoxic effector cells in co-cultures, relies on capturing the intracellular carboxyfluorescein succinimidyl ester released from lysed target cells onto the surface of the killing lymphocyte. Capture was achieved using a bispecific complex consisting of an anti-fluorescein isothiocyanate antibody linked to an antibody against the pan-leucocyte receptor CD45, which ‘painted’ the natural killer cell surface with fluorescent lysate and enabled FACS sorting followed by single-cell RNA-seq profiling of killer-cell subpopulations.”

5.Fluorescein-switching-based lateral flow assay for the detection of microRNAs.
Ryu JY, et al.
Org Biomol Chem. 2024 Oct;22(40):8182–8188. PMID: 39291769 DOI: 10.1039/d4ob01311e
“A fluorescein-switching lateral flow assay was developed for naked-eye detection of microRNA biomarkers (miR-6090 and miR-141 for prostate cancer). Reduced fluorescein on the probe only weakly binds gold-nanoparticle-conjugated anti-fluorescein antibodies; in the presence of target microRNA, riboflavin tetraacetate photo-oxidizes the probe back to native fluorescein, which strongly binds the antibodies on the strip to produce a visible line. Sodium borohydride was introduced to minimize background, enabling fmol-level microRNA detection with minimal false positives for point-of-care cancer diagnostics.”